Skip to content

Usefulness of serum Mac-2 binding protein glycosylation isomer in patients undergoing hepatectomy

Usefulness of serum Mac-2 binding protein glycosylation isomer in patients undergoing hepatectomy - Usefulness of M2BPGi in patients undergoing hepatectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000036699
Enrollment
115
Registered
2019-05-10
Start date
2018-06-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patients with liver diseases who were undergoing hepatic resections

Interventions

None listed

Sponsors

University of Miyazaki, Faculty of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients with liver diseases who were undergoing hepatic resections.

Exclusion criteria

Exclusion criteria: The patients who refuse to join in this study.

Design outcomes

Primary

MeasureTime frame
To clarify the usefulness of Mac-2 binding protein glycosylation isomer to predict the morbidity after hepatectomy.

Countries

Japan

Contacts

Public ContactMasahide Hiyoshi

Department of Surgery, University of Miyazaki, Faculty of Medicine Division of Hepato-biliary-Pancreatic Surgery

mhiyoshi@med.miyazaki-u.ac.jp0985-85-2808

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026